We are live on ! Find out more
FO

FT Options Portfolio holdings

AUM $66.4M
1-Year Est. Return 18.48%
This Fund
S&P 500
This Quarter Est. Return
+24.92%
1 Year Est. Return
+18.48%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$126M
AUM Growth
+$9.73M
Cap. Flow
+$224M
Cap. Flow %
177.31%
Top 10 Hldgs %
37.67%
Holding
493
New
153
Increased
113
Reduced
67
Closed
127

Sector Composition

1 Healthcare 39.95%
2 Consumer Staples 5.72%
3 Consumer Discretionary 5.14%
4 Technology 3.35%
5 Materials 2.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IDCC icon
401
CALL
InterDigital
IDCC
$6.86B
-12,800
Closed -$37K
IDCC icon
402
PUT
InterDigital
IDCC
$6.86B
-9,800
Closed -$27K
ILMN icon
403
CALL
Illumina
ILMN
$28.8B
-10,280
Closed -$3K
ILMN icon
404
PUT
Illumina
ILMN
$28.8B
-9,149
Closed -$3K
INFY icon
405
CALL
Infosys
INFY
$46.7B
-93,600
Closed -$4K
INFY icon
406
Infosys
INFY
$46.7B
-30,714
Closed -$274K
INFY icon
407
PUT
Infosys
INFY
$46.7B
-60,000
Closed -$14K
INSM icon
408
PUT
Insmed
INSM
$23.3B
-30,000
Closed -$100K
INTC icon
409
Intel
INTC
$487B
-1,831
Closed -$64.8K
IONS icon
410
PUT
Ionis Pharmaceuticals
IONS
$9.03B
-200
Closed -$1K
IRBT
411
DELISTED
iRobot
IRBT
-5,881
Closed -$206K
IRBT
412
PUT
DELISTED
iRobot
IRBT
-6,500
Closed -$22K
JNJ icon
413
CALL
Johnson & Johnson
JNJ
$602B
-35,000
Closed -$224K
JNJ icon
414
Johnson & Johnson
JNJ
$602B
-8,606
Closed -$1.04M
JNJ icon
415
PUT
Johnson & Johnson
JNJ
$602B
-228,700
Closed -$37K
K
416
PUT
DELISTED
Kellanova
K
-42,600
Closed -$43K
KSS icon
417
CALL
Kohl's
KSS
$1.98B
-30,000
Closed -$85K
LGND icon
418
Ligand Pharmaceuticals
LGND
$5.94B
-13,573
Closed -$997K
LGND icon
419
PUT
Ligand Pharmaceuticals
LGND
$5.94B
-32,060
Closed -$189K
LLY icon
420
PUT
Eli Lilly
LLY
$1.04T
-140,000
Closed -$70K
LPCN icon
421
Lipocine
LPCN
$18.9M
-106
Closed -$5K
LPCN icon
422
PUT
Lipocine
LPCN
$18.9M
-371
Closed -$4K
LRCX icon
423
CALL
Lam Research
LRCX
$401B
-200,000
Closed -$21K
LULU icon
424
lululemon athletica
LULU
$13.5B
-3,100
Closed -$229K
LULU icon
425
PUT
lululemon athletica
LULU
$13.5B
-15,500
Closed -$56K

Similar funds

FT Options's Q3 2016 Portfolio in Review

As of Q3 2016, FT Options held 493 positions worth $126M, up 8.4% from $116M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

FT Options deployed $224M of net new capital in Q3 2016, opening 153 new positions and adding to 113 existing holdings. Its largest new stake was iShares Biotechnology ETF: 21,000 shares worth $2.03M.

By sector, the portfolio is most concentrated in Healthcare at 40% of assets, down from 41% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

On the sell side, the largest reduction was Apple, an estimated $2.74M trimmed.

  • FT Options's largest Q3 2016 buy was iShares Biotechnology ETF: 21,000 shares worth $2.03M.
  • FT Options added most to Procter & Gamble in Q3 2016, an estimated $3.82M increase.
  • FT Options's biggest Q3 2016 reduction was Apple, cutting an estimated $2.74M.
  • FT Options fully exited MEDIVATION, INC. in Q3 2016, selling an estimated $7.18M.
  • FT Options's ten largest holdings make up 38% of its $126M portfolio in Q3 2016.
  • FT Options opened 153 new positions and closed 127 in Q3 2016.
  • FT Options's portfolio value rose 8.4% quarter-over-quarter to $126M.

Based on FT Options's 13F filing for Q3 2016, filed 10 Nov 2016.